Effects of a short-term suspension of hormone replacement therapy on mammographic density

Fertility and Sterility

Volumn 76, Issue 3, 2001, Pages 451-455

  Colacurci, Nicola ^a,c   Fornaro, Felice ^a   De Franciscis, Pasquale ^a   Mele, Daniela ^a   Palermo, Mario ^b   Del Vecchio, Walter ^b  

^a Institute of Gynecology and Obstetrics   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NONE   (Italy)

Author keywords

Breast; Hormone replacement therapy; Mammography; Postmenopause

Indexed keywords

ESTROGEN; NOMEGESTROL ACETATE;

ADULT; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; BONE DENSITY; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FOLLICLE STIMULATING HORMONE; HUMANS; HYSTERECTOMY; MAMMOGRAPHY; MEGESTROL; MENOPAUSE; MIDDLE AGED; NORPREGNADIENES; PARITY; POSTMENOPAUSE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0034892490     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(01)01967-7     Document Type: Article

References (26)

1. Oestrogen therapy and the menopausal syndrome
2. Postmenopausal estrogen therapy and cardiovascular disease
3. Long-term estrogen replacement therapy prevents bone loss and fractures
4. What do women want?
5. A study to examine women's knowledge, perception and acceptability of hormone replacement therapy
6. Breast cancer and hormone replacement therapy; collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer
7. The benefits and risks of mammographic screening for breast cancer
8. Case-control study of factors associated with failure to detect breast cancer by mammography
9. Effect of mammographic breast density on breast cancer screening performance; a study in Nijmegen, the Netherlands
10. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities; a case-control study
11. Hormonal replacement therapy; mammographic manifestation
12. Pain and increased mammographic density in women receiving hormone replacement therapy; a prospective study
13. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern
14. Effects of tibolone on the breast
15. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography
16. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme
17. Effect of hormone replacement therapy on cancer detection by mammography
18. Hormone replacement therapy and accuracy of mammographic screening
19. Effects of estrogen on screening mammography; another complexity
20. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity
21. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density
22. Mammographic changes in postmenopausal women on hormone replacement therapy
23. Mammographic breast density during hormone replacement therapy; differences according to treatment
24. Mammographic and ultrasonographic study of changes in the breast related to HRT
25. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast
26. A correlative morphologic study of the human breast and endothelium in the menstrual cycle